Valuation: EUROAPI

Market Cap 120M 138M 112M 103M 193M 13.18B 198M 1.33B 519M 6.54B 517M 506M 22.51B P/E 2026 *
-1.58x
P/E 2027 * -2.98x
Enterprise Value 78.47M 90.01M 73.24M 67.31M 126M 8.61B 129M 868M 339M 4.27B 338M 330M 14.7B EV / Sales 2026 *
0.1x
EV / Sales 2027 * 0.15x
Free-Float
65.03%
Yield 2026 *
-
Yield 2027 * -
1 day+1.52%
1 week-0.47%
Current month-4.89%
1 month-3.38%
3 months-7.39%
6 months-42.18%
Current year-44.10%
1 week 1.22
Extreme 1.22
1.27
1 month 1.22
Extreme 1.22
1.38
Current year 1.22
Extreme 1.22
2.26
1 year 1.22
Extreme 1.22
3.41
3 years 1.22
Extreme 1.22
12.96
5 years 1.22
Extreme 1.22
18.92
10 years 1.22
Extreme 1.22
18.92
Manager TitleAgeSince
Chief Executive Officer - 08/12/2024
Director of Finance/CFO - 16/10/2024
Compliance Officer - 26/11/2023
Director TitleAgeSince
Director/Board Member 62 05/05/2022
Director/Board Member - 05/05/2022
Chairman 57 08/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
+1.52%-0.47% - - 134M
-0.87%+2.94%+49.73%+163.92% 1,089B
-0.45%+5.95%+59.75%+52.18% 643B
+0.04%+2.81%+39.67%+74.54% 465B
-1.69%+8.36%+38.80%+34.26% 359B
-0.51%+3.35%+39.00%+43.76% 303B
+1.50%+5.14%+21.72%+18.77% 267B
+0.79%+4.32%-25.07%-36.02% 226B
-1.39%+5.84%+28.66%+64.00% 212B
-1.18%+1.88%+17.43%+72.69% 167B
Average -0.41%+5.07%+29.96%+54.23% 414.57B
Weighted average by Cap. -0.68%+5.14%+39.10%+79.01%

Financials

2026 *2027 *
Net sales 760M 872M 710M 652M 1.22B 83.43B 1.25B 8.41B 3.29B 41.39B 3.28B 3.2B 143B 782M 897M 730M 670M 1.26B 85.75B 1.29B 8.65B 3.38B 42.54B 3.37B 3.29B 146B
Net income -75.7M -86.84M -70.66M -64.94M -122M -8.31B -125M -837M -327M -4.12B -326M -319M -14.19B -40.25M -46.18M -37.57M -34.53M -64.81M -4.42B -66.33M -445M -174M -2.19B -173M -170M -7.54B
Net Debt -41.66M -47.79M -38.89M -35.74M -67.08M -4.57B -68.65M -461M -180M -2.27B -179M -175M -7.81B -5.06M -5.81M -4.73M -4.34M -8.15M -555M -8.34M -56.01M -21.89M -276M -21.81M -21.32M -949M
Logo EUROAPI
EUROAPI specializes in the development and manufacture of active pharmaceutical ingredients on behalf of healthcare industries. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. EUROAPI has 5 production sites located in France (2), Germany, Italy and Hungary.
Employees
2,961
Date Price Change Volume
29/07/26 €1.270 +3.08% 46
28/07/26 €1.232 0.00% 2,198
27/07/26 €1.232 +0.33% 15
24/07/26 €1.228 -0.16% 2,117
23/07/26 €1.230 -3.45% 5,044
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
4
Last Close Price
1.262EUR
Average target price
1.475EUR
Spread / Average Target
+16.88%

Quarterly revenue - Rate of surprise